SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-048047
Filing Date
2022-08-15
Accepted
2022-08-15 16:17:25
Documents
52
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_virpaxpharma.htm   iXBRL 10-Q 536860
2 CERTIFICATION f10q0622ex31-1_virpaxpharma.htm EX-31.1 9486
3 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER f10q0622ex31-2_virpaxpharma.htm EX-31.2 10058
4 CERTIFICATION f10q0622ex32-1_virpaxpharma.htm EX-32.1 5400
5 CERTIFICATION f10q0622ex32-2_virpaxpharma.htm EX-32.2 5204
  Complete submission text file 0001213900-22-048047.txt   3138727

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vrpx-20220630.xsd EX-101.SCH 40509
7 XBRL CALCULATION FILE vrpx-20220630_cal.xml EX-101.CAL 19635
8 XBRL DEFINITION FILE vrpx-20220630_def.xml EX-101.DEF 156650
9 XBRL LABEL FILE vrpx-20220630_lab.xml EX-101.LAB 344708
10 XBRL PRESENTATION FILE vrpx-20220630_pre.xml EX-101.PRE 167013
46 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_virpaxpharma_htm.xml XML 296609
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40064 | Film No.: 221165847
SIC: 2834 Pharmaceutical Preparations